Skip to content

Clinical trials

Phase 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Phase: Phase 2 Country / region: Italy Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20052
20171
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center3
Daiichi Sankyo1
European Organisation for Research and Treatment of Cancer - EORTC1
Gruppo Italiano Malattie EMatologiche dell'Adulto1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma7
Burkitt Lymphoma4
Hodgkin Disease4
Immunoblastic Lymphadenopathy4
Leukemia, Hairy Cell4
Leukemia, Lymphocytic, Chronic, B-Cell4
Leukemia, Myeloid, Acute4
Leukemia, Myeloid, Chronic-Phase4
Lymphoma, B-Cell, Marginal Zone4
Lymphoma, Follicular4

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.